Baeyer-Villiger Monooxygenases EthA and MymA Are Required for Activation of Replicating and Non-replicating Mycobacterium tuberculosis Inhibitors-Reference-Cited by-同舟云学术

Baeyer-Villiger Monooxygenases EthA and MymA Are Required for Activation of Replicating and Non-replicating Mycobacterium tuberculosis Inhibitors

Published:2016-06 Issue:6 Volume:23 Page:666-677
ISSN:2451-9456
Container-title:Cell Chemical Biology
language:en
Short-container-title:Cell Chemical Biology

Author:

Grant Sarah Schmidt,Wellington Samantha,Kawate Tomohiko,Desjardins Christopher A.,Silvis Melanie R.,Wivagg Carl,Thompson Matthew,Gordon Katherine,Kazyanskaya Edward,Nietupski Raymond,Haseley Nathan,Iwase Noriaki,Earl Ashlee M.,Fitzgerald Michael,Hung Deborah T.

Funder

NIH

Bill and Melinda Gates Foundation

National Institute of Allergy and Infectious Diseases

Department of Health and Human Services

Publisher

Elsevier BV

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Biology,Molecular Medicine,Biochemistry

Reference36 articles.

1. A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis;Andries;Science,2005

2. Use of genomics and combinatorial chemistry in the development of new antimycobacterial drugs;Barry;Biochem. Pharmacol.,2000